Korro Bio, Inc.
Korro Bio, Inc. scores highest on Price (37) and lowest on Nitro (25). Its PosiPenta is 31.00 out of 100, weaker than most similar companies.
On the Penta Grid this week, Korro Bio, Inc. is Grid #748 of 837 in the Healthcare sector in United States, and Grid #3,563 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Korro Bio, Inc. | 31.00 | 37 | 34 | 25 | 31 | 27 |
| Invivyd, Inc. | 39.12 | 39 | 38 | 23 | 45 | 50 |
| Alpha Cognition Inc. Common Stock | 51.37 | 20 | 51 | 81 | 68 | 37 |
| Exagen Inc. | 37.70 | 4 | 52 | 69 | 17 | 46 |
| Yarrow Bioscience Inc | 43.02 | 18 | — | 34 | 88 | 32 |
| Sionna Therapeutics, Inc. | 37.60 | 44 | 26 | 8 | 62 | 48 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.86 |
| P/B ratio | 1.21 |
EEarnings
| Trailing EPS | ₹-935.78 |
| Forward EPS | ₹-418.76 |
NNitro
| Price | 804.13 |
| 52-week high | 4778.37 |
| 52-week low | 492.90 |
| Fall from 52-week high | 83.2% |
TTorque
| Return on equity (ROE) | -97.69% |
| Debt-to-equity | 0.41 |
AAnchor
| Beta (price swings) | 2.36 |
| Market cap | ₹1,184 Cr |
| Insider holding | 0.89% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Korro Bio, Inc.'s PosiPenta score?
Korro Bio, Inc.'s PosiPenta is 31.00 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Korro Bio, Inc. stand on the Penta Grid?
On the Penta Grid this week, Korro Bio, Inc. is Grid #748 of 837 in the Healthcare sector in United States, and Grid #3,563 of 4,000 in United States.
Which PosiPenta pillar is strongest for Korro Bio, Inc.?
Price (valuation), with a score of 37 out of 100: weaker than most similar companies.
Which PosiPenta pillar is weakest for Korro Bio, Inc.?
Nitro (momentum), with a score of 25 out of 100: weaker than most similar companies.
Has Korro Bio, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.59 points, from 27.41 to 31.00.
PositoAI is for research and education only and is not investment advice.